Home / Restalyst / Restalyst received Singapore HSA Provisional Authorization approval for RAPIT COVID-19 IgM/IgG Test Kit

July 01, 2020 Restalyst

This a lateral flow chromatography immunoassay intended for the qualitative detection and differentiation of IgM and IgG antibodies against SARS-CoV-2 in human plasma, serum, finger pricked whole blood or whole blood.